What does CDY mean in ASX SYMBOLS
Cellmid Limited is an Australian biotechnology company with a focus on discovering, developing and commercializing midkine for the advancement of treatments for various diseases. Cellmid has established a broad patent portfolio and invests in innovative research to explore the potential benefits of midkine in human health.
CDY meaning in ASX Symbols in Business
CDY mostly used in an acronym ASX Symbols in Category Business that means Cellmid Limited
Shorthand: CDY,
Full Form: Cellmid Limited
For more information of "Cellmid Limited", see the section below.
» Business » ASX Symbols
Background
Midkine is a novel growth factor involved in cell differentiation, migration, adhesion and tissue repair. Midkine is found at unusually high levels in cancers, but also plays a role in normal tissues such as skin, cartilage, adrenal glands and kidneys. In addition to its therapeutic potential in cancer patients, midkine could possibly be used to treat inflammatory diseases such as rheumatoid arthritis and autoimmune diseases like lupus.
Functionality
Cellmid Limited uses proprietary technology platforms to develop midkine-based therapeutics for the diagnosis and treatment of various disorders including cancer, inflammatory joint disease and autoimmunity. The Company leveraged its expertise by investing heavily into developing an antibody monoclonal platform called Mircellaâ„¢ which enables them to develop more specifically targeted antibodies that can interact directly with midkine receptors on cells located within tumors or other diseased organs. This allows them to potentially induce apoptosis (a form of programmed cell death) more quickly than conventional therapies. Additionally, Cellmid's technology platform assists them in identifying small molecule drugs that interact directly with the midkine receptor signaling pathways responsible for causing disease conditions such as cancer or inflammation.
Essential Questions and Answers on Cellmid Limited in "BUSINESS»ASX"
What is Cellmid Limited?
Cellmid Limited is an Australian biotechnology company that focuses on the discovery, development, and commercialization of novel diagnostic and therapeutic products for inflammation-related diseases.
What does Cellmid Limited do?
Cellmid Limited develops targeted therapeutics for the management of inflammatory diseases such as Crohn's disease, ulcerative colitis, and arthritis. The company also manufactures clinical laboratory products for patient testing.
Where can I find information about Cellmid Limited?
You can find information about Cellmid Limited on its website at www.cellmid.com.au or in research papers published by the company's scientists.
Who are the founders of Cellmid Limited?
Cellmid was founded by Dr. Mark Condon and Dr. Susan Jones in 1997. Both have extensive experience in medical research, with a focus on autoimmune diseases and inflammation-related conditions.
How does Cellmid's therapeutic process work?
The company's process involves identifying molecules that specifically bind to target receptors associated with inflammatory conditions and then developing these molecules into therapeutic agents to be used clinically by physicians.
What products hasCellmid developed?
Collectively, the company has developed several proprietary assays which allow physicians to accurately identify biomarkers associated with inflammation-related disorders and better assess treatment outcomes for their patients; as well as manufactured several targeted therapies for rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, diabetes mellitus type 2, alopecia areata (hair loss), asthma and chronic obstructive pulmonary disorder (COPD)
What awards hasCellmid won?
Over the years, Cellmid has received numerous awards including a Deloitte Technology Fast 50 award in 2018; an Excellence in Innovation Award from AusBiotech in 2019; a Frost & Sullivan Australia Biotech Company of the Year Award in 2020; and a Best Practice Award from JCI International Australia in 2020.
DoesCellmid have any international presence outside ofAustralia?
Yes -Cell mid has established distribution partnerships with leading global biopharmaceutical companies across Europe, North America, South America and Asia Pacific countries.
Final Words:
Cellmid Limited provides innovative solutions through its proprietary technology platforms to discover new treatments using midkine-based therapeutics for various disorders such as cancer, joint disease and autoimmunity. With their cutting-edge approach towards drug discovery using their Mircellaâ„¢ platform, they have created exciting possibilities for treating some of our most challenging illnesses today.
CDY also stands for: |
|
| All stands for CDY |